News & EventsVivacta re-aligns management in preparation for £4 million financing round
26th August 2010
Read more

Biosensors 20th Annual World Congress (Glasgow)
25th – 28th May 2010
www.biosensors-congress.elsevier.com/

Vivacta present at Deutsche Bank 35th Annual Health Care Conference
3rd May 2010
Boston, MA, InterContinental

Vivacta raises $4.5 million to commercialise piezofilm technology
17 June 2009
Vivacta has closed a $4.5 million financing round that was fully subscribed by existing investors.
Read more

Vivacta’s Quality Management System certified to ISO 13485:2003
19 January 2009
Vivacta has taken an important step towards the successful commercialisation of its ultrasensitive point-of-care immunochemistry system. Read more

Vivacta gears up for pilot manufacture of piezofilm assays
10 July 2008
Vivacta is gearing up for pilot manufacture of its highly sensitive, disposable piezofilm sensors for point-of-care (PoC) diagnostics. Read more

Vivacta raises $12 million to commercialise piezofilm technology
27 November 2007
First point-of-care clinical evaluation scheduled for 2008. Read more

Vivacta fills key Management Position
19 January 2007
Sonja Johnston is appointed as Quality Manager. Read more

Vivacta Strengthens its Position in Point-of-Care Diagnostics
11 October 2006
Mr Rolf Classon and Dr Werner Schafer appointed Board Directors. Read more

New name and branding
7 August 2006
PanOpSys has now been relaunched as Vivacta. Read more

Series A investment
16 February 2006
PanOpSys Limited close a $5.25 million Series A investment with Quester Capital Management. Read more